期刊文献+

2-[(2-乙基-5-氟苯并呋喃-3-基)甲基]-4-甲基-5-噻唑甲酸合成路线的改进

Improved Synthesis of 2-((2-Ethyl-5-fluorobenzofuran-3-yl)methyl)-4-methylthiazole-5-carboxylic acid
下载PDF
导出
摘要 在课题组前期2-[(2-乙基-5-氟苯并呋喃-3-基)甲基]-4-甲基-5-噻唑甲酸合成路线的基础上进行改进,以5-氟水杨醛为起始原料,经环合、还原、亲电取代、硫代、环合、水解反应得到目标化合物,化合物结构经^(1)HNMR、^(13)CNMR和HRMS确证。与原合成路线相比,该路线减少了合成步骤,目标化合物总收率由0.3%提高到5.0%。 On the basis of the synthetic route of the target compound 2-((2-ethyl-5-fluorobenzofuran-3-yl)methyl)-4-methylthiazole-5-carboxylic acid at early stage,we further improved the synthetic route and obtained the target compound from 5-fluorsalicylaldehyde by cyclization,reduction,electrophilic substitution,thiosubstitution,cyclization,and hydrolysis.Moreover,we identified the structures of the compounds by^(1)HNMR,^(13)CNMR,and HRMS.Compared with the original synthetic route,the synthesis steps of the optimized route reduces and the total yield of the target compound increases from 0.3%to 5.0%.
作者 谢珺 崔杏 王建塔 汤磊 XIE Jun;CUI Xing;WANG Jianta;TANG Lei(College of Pharmacy,Guizhou Medical University,Guiyang 550025,China;Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D,Guiyang 550004,China)
出处 《化学与生物工程》 CAS 2023年第7期30-33,共4页 Chemistry & Bioengineering
基金 2023年度贵州省卫生健康委科学技术基金项目(gzwkj2023-232) 化学药仿创技术应用国家地方联合工程技术研究中心项目(2019) 贵州省常见重大慢性疾病发病机制及药物开发应用创新基地项目(黔科中引地[2021]4029)。
关键词 黄嘌呤氧化酶 2-[(2-乙基-5-氟苯并呋喃-3-基)甲基]-4-甲基-5-噻唑甲酸 合成 改进 xanthine oxidase 2-((2-ethyl-5-fluorobenzofuran-3-yl)methyl)-4-methylthiazole-5-carboxylic acid synthesis improvement
  • 相关文献

参考文献2

二级参考文献14

  • 1[1]Bisagni E,Buu-Hoi N P,Royer R.Oxygen hetercocycles. Part Ⅶ The reactivity of benzofuran and 2-alkylbenzofurans[J].J Chem Soc,1955,77:35628-35688.
  • 2[2]Buu-Hoi N P,Bisagni E,Royer R,et al.Oxygen heterocycles. Part Ⅶ Spasmoytic ketones in the bebzofuran series,and realated comp; ounds[J].J Chem Soc,1957,79:625-628.
  • 3[3]Materoni E,Hono K.The synhesis of benzofurans[J].Ber,1903,36:2864-2868.
  • 4[4]Cheireer S,Giotine D.The reactivity and synthesis of 2-alkylbenzofurans[P].EP: 1 320 001,1978-09-12.
  • 5[5]Hartmut V.HPLC of benzobromarone[J].J Chromat,1980,56:383-384.
  • 6MICHACEL E E,MICHELLE A F.Febuxostat:a selective xanthine oxidase/xanthine dehydrogenase inhibitor for the management of hyperuricemia in adults with gout[J].Clin Ther,2009,31(11):2503-2518.
  • 7KONDA S,FUKUSHIMA H,HASEGAWA M,et al.2-Arylthiazole derivative and pharmaceutical composition containing the same:EP,0513379[P].1992-06-11.
  • 8WATANABE K,FUJII T,TANAKA T,et al.Preparation method of 2-(4-alkoxy-3-cyanophenyl)thiazol derives and novel intermdiates for the synthesis of them:JP,1994329647[P].1994-11-29.
  • 9WATANABE K,YARIO T,HIRATSU T.Preparation method of 2-(4-alkoxy-3-cyanophenyl)thiazole derivatives:JP,1998045733[P].1998-02-17.
  • 10王绍杰,陈家润,薛明星.一种2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸的合成方法:中国,101497589A[P].2009-08-05.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部